脑海绵状血管畸形临床管理指南概要:基于系统文献综述的血管瘤联盟科学顾问委员会临床专家小组共识推荐
血管瘤联盟召集多学科专家组,系统检索1983年1月1日至2014年9月31日发表的1270篇文献并纳入98篇及38篇近期相关文献,围绕5个主题制定23条共识推荐,按AHA/ASA标准分级:无A级推荐,B级11条(48%),C级12条(52%);I级8条(35%),II级10条(43%),III级5条(22%)。
要点
- 共形成23条脑海绵状血管畸形管理共识推荐,无A级推荐,B级11条、C级12条。
- 推荐等级I级8条、II级10条、III级5条,按AHA/ASA标准分级。
- 完整推荐文档及争议与知识空白总结见www.angioma.org/CCMGuidelines。
核心结论
- 当前证据支持脑海绵状血管畸形的管理推荐,但推荐级别和等级普遍较低,需要进一步研究以更好指导临床实践并更新推荐。
研究设计与样本
- 血管瘤联盟科学顾问委员会临床专家小组召集多学科写作组,按预设方案系统检索1983年1月1日至2014年9月31日发表的1270篇文献,基于方法学标准纳入98篇并补充38篇近期或相关文献,对证据评级并形成共识推荐,推荐按AHA/ASA标准进行类别(效应大小)和级别(确定性估计)分级。
诊断标准与关键数值
- 共形成23条共识管理推荐,按AHA/ASA标准分级:无A级推荐,B级11条(48%),C级12条(52%)。
- 推荐类别:I级8条(35%),II级10条(43%),III级5条(22%)。
- 完整推荐文档(含引用选择标准、各推荐详细依据及争议与知识空白总结)见www.angioma.org/CCMGuidelines。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 无A级推荐,因缺乏随机对照试验。
- 推荐级别和等级普遍较低,需要进一步研究以更好指导临床实践并更新推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Despite many publications about cerebral cavernous malformations (CCMs), controversy remains regarding diagnostic and management strategies.
OBJECTIVE: To develop guidelines for CCM management.
METHODS: The Angioma Alliance ( www.angioma.org ), the patient support group in the United States advocating on behalf of patients and research in CCM, convened a multidisciplinary writing group comprising expert CCM clinicians to help summarize the existing literature related to the clinical care of CCM, focusing on 5 topics: (1) epidemiology and natural history, (2) genetic testing and counseling, (3) diagnostic criteria and radiology standards, (4) neurosurgical considerations, and (5) neurological considerations. The group reviewed literature, rated evidence, developed recommendations, and established consensus, controversies, and knowledge gaps according to a prespecified protocol.
RESULTS: Of 1270 publications published between January 1, 1983 and September 31, 2014, we selected 98 based on methodological criteria, and identified 38 additional recent or relevant publications. Topic authors used these publications to summarize current knowledge and arrive at 23 consensus management recommendations, which we rated by class (size of effect) and level (estimate of certainty) according to the American Heart Association/American Stroke Association criteria. No recommendation was level A (because of the absence of randomized controlled trials), 11 (48%) were level B, and 12 (52%) were level C. Recommendations were class I in 8 (35%), class II in 10 (43%), and class III in 5 (22%).
CONCLUSION: Current evidence supports recommendations for the management of CCM, but their generally low levels and classes mandate further research to better inform clinical practice and update these recommendations. The complete recommendations document, including the criteria for selecting reference citations, a more detailed justification of the respective recommendations, and a summary of controversies and knowledge gaps, was similarly peer reviewed and is available on line www.angioma.org/CCMGuidelines .
引用
- Akers A, Al-Shahi Salman R, A Awad I, et al. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery. 2017. PMID: 28387823. doi:10.1093/neuros/nyx091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。